ClinicalTrials.Veeva

Menu

Osteogenic Effects in Human Mesenchymal Stem Cells Enhanced by Wnt Signaling

C

China Medical University

Status

Completed

Conditions

Primary Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01323894
DMR-99-IRB-122

Details and patient eligibility

About

The first year purpose:

The best concentration of canonical Wnt3a will be investigated in promoting the osteoblastogenesis of human mesenchymal stem cells.

Full description

Our previous work is investigating the viral (Adv-BMP-2) administration for the development of a model to generate bones for possible use in clinical settings; the non-viral and viral administrations will be compared for best osteogenesis effects.

The first year purpose:

The best concentration of canonical Wnt3a will be investigated in promoting the osteoblastogenesis of human mesenchymal stem cells.

Enrollment

3 patients

Sex

All

Ages

10 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age above 10 years old
  • The patients require surgery ner iliac or abdomen areas

Exclusion criteria

  • age below 10 years old

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems